COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics to Present at Jefferies 2018 Global Healthcare Conference on Thursday, June 7th

31/05/2018 - 13:00

BOULDER, Colo., May 31, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]

T2 Biosystems Announces Pricing of Public Offering of Common Stock

31/05/2018 - 13:00

LEXINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) today announced the pricing of an underwritten registered public offering of 6,100,000 shares of common stock at a public offering [...]

Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO

31/05/2018 - 13:00

Industry veteran Dr. Peter Farrell named as Chairman of the Board, Dr. Pad Chivukula reinstated as CSO and COO SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA [...]

Axovant to Present at Two Upcoming Investor Conferences

31/05/2018 - 13:00

BASEL, Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies 2018 Global [...]

Apellis Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

31/05/2018 - 13:00

CRESTWOOD, Ky. and CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

BeyondSpring to Present at Upcoming Conferences

31/05/2018 - 13:00

NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that [...]

Dova Pharmaceuticals Announces Availability of DOPTELET® in the United States

31/05/2018 - 13:00

DURHAM, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the availability of DOPTELET in the United States for the treatment of thrombocytopenia in adult patients with [...]

Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015

31/05/2018 - 13:00

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK ), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in [...]

Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcoholic Steatohepatitis (NASH) at 36 Weeks in Phase 2 Clinical Trial

31/05/2018 - 12:50

-- Statistically significantly more patients treated with MGL-3196 compared with placebo treated patients achieved a two point reduction in NAS (NAFLD activity score) on biopsy -- -- Statistically significantly more [...]

Clementia to Present at the Jefferies 2018 Global Healthcare Conference

31/05/2018 - 12:30

MONTREAL, May 31, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), a clinical-stage biopharmaceutical company innovating new treatments for people with ultra-rare bone disorders and other [...]

Clementia Annonce qu’elle Participera à la Conférence Annuelle 2018 sur les Soins de Santé Jefferies (« Jefferies 2018 Global Healthcare Conference »)

31/05/2018 - 12:30

MONTRÉAL, 31 mai 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: CMTA ), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]

Nightstar Therapeutics to Present at Jefferies 2018 Global Healthcare Conference

31/05/2018 - 12:30

LEXINGTON, Mass. and LONDON, May 31, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ: NITE ), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]

CorVel Announces Revenues and Earnings

31/05/2018 - 12:15

IRVINE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL ) announced the results for the quarter and fiscal year ended March 31, 2018. Revenues for the quarter ended March 31, 2018 were $144 [...]

PotNetwork Holdings, Inc. Builds on Diamond CBD’s Recent Growth By Stocking Pet Industry Retailers With An Expanding Selection of “MediPets” Premium Quality Supplements and Tasty Treats for Their Customers

31/05/2018 - 12:00

Company Continues Strengthening Presence in Billion Dollar Pet Sector FT LAUDERDALE, Fla., May 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) (“Company”) wholly owned subsidiary [...]

Zealand Pharma will attend the Jefferies Global Healthcare Conference on June 5-8, 2018 in New York

31/05/2018 - 11:11

Press release - No. 13 / 2018 Zealand Pharma will attend the Jefferies Global Healthcare Conference on June 5-8, 2018 in New York Copenhagen, May 31, 2018 - Mats Blom, Executive Vice President and Chief Financial [...]

Zealand announces amendments to its Articles of Association following the granting of warrants

31/05/2018 - 11:10

Company announcement - No. 17/2018 Zealand announces amendments to its Articles of Association following the granting of warrants Copenhagen, May 31, 2018 - Zealand Pharma ("Zealand") announces that its Articles of [...]

William Demant Holding A/S: Total number of voting rights and capital

31/05/2018 - 10:30

Company announcement no 2018-07 31 May 2018 Change in the share capital in William Demant Holding A/S With reference to Company Announcement no 2018-05, it was decided at William Demant Holding A/S’ ordinary general [...]

Veritas Pharma Provides Corporate Update on Q2 2018

31/05/2018 - 09:10

VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to provide a corporate update on its achievements, [...]

Number of shares and votes in Active Biotech

31/05/2018 - 08:31

The number of shares and votes in Active Biotech has changed as a result of the recently completed rights issue. Today, the last trading day of the month, there are in total 145,236,480 shares and votes in Active [...]